High impact
[Virginia] Carelon Medical Benefits Management Clinical Appropriateness Guidelines updates
Anthem BCBS·Effective Nov 15, 2026
Carelon (Anthem Medicare Advantage Virginia) updated clinical appropriateness guidelines effective November 15, 2026, expanding coverage for genetic/molecular testing in multiple cancer types (breast, prostate, lung, thyroid, etc.), hematologic malignancies, and orthopedic procedures. Key changes include new drug therapies triggering testing requirements (imlunestrant, niraparib), broadened indications for existing tests, and standardized 12-week conservative management requirements for joint surgery. Practices must update prior authorization criteria, clinical documentation templates, and testing protocols to align with expanded coverage.